Biotech Companies Warming to Social Media

Recently, Oprah Winfrey came under fireapplications, such as Tweetscan and Twist, that allow
from Newsweek magazine in an article ironicallycompanies to monitor and analyze what people are
titled "Live Your Best Life Ever!" Authors Westontweeting about specific topics. “Think of how
Kosova and Pat Wingert took on the one of theuseful that is in a crisis situation,” wrote Mark
most powerful people in media by saying thatSenak of Fleishman-Hillard in his EyeOnFDA blog.
Winfrey, on her show and through her ever growing“You can monitor what people are saying about
online social network, often promotes unprovenyour crisis, discern the messaging, develop your own
health "cures" to her throngs of fans. response document and send it out directly to those
Doctors and readers reacted in droves, manywho have been talking about it via Twitter.”
agreeing with the authors' stance on Winfrey'sLife science companies are watching for signals from
championing of misinformation. Whilethe Food and Drug Administration on how the use of
the Newsweek story was certainly in the spotlight,social media might be regulated. The FDA, which
it proves that everyone needs to be exceedinglycarefully monitors the pharmaceutical industry in its
careful in the medical advice they give through themessaging to consumers, recently admonished a
media, whether something as powerful as The Oprahpharmaceutical company for posting a video on
Winfrey Show or as small as a Twitter feed. YouTube. The regulators took exception to certain
While most businesses are racing to explore how toclaims made in the video as well as important
leverage the social media phenomenon to theirinformation that the FDA said was left out.  The
advantage -- Facebook pages, RSS feeds, YouTubeuse of YouTube as a communications vehicle,
and even Twitter are increasingly in the marketinghowever, was not addressed – a fact that was
and PR mix for consumer-facing companies -- biotechduly noted and widely reported by bloggers. "It's not
firms have been slow to test the social mediathe medium, it's the message," Dr. Jean Ah Kang of
waters. The regulatory environment and risk aversionthe FDA's Division for Drug Marketing, Advertising
are legitimate concerns.  But many close to theand Communications, told Senak in a recent interview.
industry believe that biotech, among the mostPharmaceutical companies are well aware that
technology-oriented of all industries, needs to bedirect-to-consumer advertising is likely to be under
more aggressive in its approach.review by the Obama Administration as part of the
“Social networks hold tremendous promise andbroader health care reform initiative.  While new
opportunity for biotech companies to enhance theirguidelines may be created, it’s likely that
consumer marketing,” said Mouli Cohen, Ecast“the message, not the medium” will continue
and Voltage Capital founder, who heads a ventureto be the overarching policy, and social media
firm that invests in biotech startups.  “Thewon’t specifically be restricted.
Internet is the primary way consumers search for“The Obama administration is extremely Internet
and find information on health issues and treatmentsavvy and its ability to harness social media played a
options, but how reliable are the sources of all thatbig role in the election, so I expect them to have an
information?  Social media is a logical extension of ainformed and sophisticated position in terms of how
company's online presence, and one that providesthey regulate the use of social media by
new opportunities to engage consumers and makebusiness,” said Cohen.
sure the information they receive about drugs orBe that as it may, most pundits expect biotech and
medical devices is accurate.”pharma companies to continue to proceed with
Pushing information out to consumers is only onecaution.  Cohen, however, thinks they should forge
facet of the power of social networks.  Socialahead.  “There is too much upside and
networks are about making connections, and lifeopportunity that social media offers.  The challenge
science companies can harness blogs and networksis to utilize social media in the way it’s meant to
like Facebook to facilitate interactions amongbe used – as an engagement tool that facilitates
consumers who share common health conditions andtwo-way communication and adds real value for
concerns. consumers. The companies that harness the power
The ability to monitor what consumers are saying isof social media will gain a competitive advantage and
equally valuable. Twitter has spawned a host of onlineenhance their reputations in the process.